Clinical Trial Update: Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating paroxetine-CR (Paxil-CR) for fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Paroxetine-CR (Paxil-CR) (paroxetine controlled-release)

Snippet

Sponsor: Duke University | Conditions: Fibromyalgia Syndrome | Phase 4 | Status: COMPLETED